Oncology Dominates China's 43 New Approvals In 2021, Domestics Emerge To Lead Innovation

BeiGene, Hengrui Head Local R&D Push

 
• By Brian Yang
  
China flag with pills (Pink Sheet Perspectives)
2021 CHINA NEW DRUG APPROVALS SHOW DOMESTICS CATCHING UP WITH MNCS • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from China

More from Asia